Clinical Trials Logo

Pain clinical trials

View clinical trials related to Pain.

Filter by:

NCT ID: NCT00818415 Completed - Pain Clinical Trials

Naproxen Sodium ER Pharmacokinetic Study

Start date: November 2008
Phase: Phase 1
Study type: Interventional

To determine the pharmacokinetic profile of the investigational product following dosing under fed conditions.

NCT ID: NCT00816751 Completed - Pain Clinical Trials

Paracervical Versus Intracervical Lidocaine

Start date: December 2007
Phase: N/A
Study type: Interventional

The aim of this study is to estimate the efficacy of intracervical versus paracervical block on pain experienced during first trimester suction curettage without the use of preoperative cervical ripening. Because of the theoretical improved reliability of stromal block, the investigators hypothesize that intracervical block would produce lower pain scores than paracervical block at the time of cervical dilation.

NCT ID: NCT00815503 Completed - Pain Clinical Trials

Postoperative Analgesia With Local Infiltration After Periacetabular Osteotomy

Start date: January 2009
Phase: Phase 4
Study type: Interventional

Pain treatment after periacetabular osteotomy is traditionally based on systemic opioids wich have side effects. The purpose of this study is to evaluate the analgetic effect of wound infiltration with local anaesthesia after periacetabular osteotomy.

NCT ID: NCT00812305 Completed - Pain Clinical Trials

Hepatic Impairment Study: Pharmacokinetics in Healthy and Hepatically Impaired Subjects

Start date: January 2009
Phase: Phase 1
Study type: Interventional

Review differences between how a healthy person and how a person with liver problems handles the study drug.

NCT ID: NCT00810121 Completed - Pain Clinical Trials

Study of Non Inferiority Bi-Profenid® 200mg Versus Bi-Profenid® 300mg Among Patients Presenting of the Post-traumatic or Rheumatologic Acute Affections of the Locomotor Apparatus (BIPROPAIN)

Start date: November 2008
Phase: Phase 3
Study type: Interventional

Primary objective: To demonstrate the non-inferiority of Bi-Profenid 100 mg x 2 day versus Bi-Profenid 150 mg x 2 day in patients presenting with pain related to closed, benign, acute post-traumatic conditions of the motor system or acute, non-infectious rheumatologic conditions, by comparing, on the one hand, changes in resting pain intensity over the entire day, measured at the end of the day using a numeric scale (NS), over 5 days and, on the other hand, total intake over 5 days of concomitant analgesics. Secondary Objectives: - To describe concomitant analgesic treatments - To describe the time between baseline and use of a step I, II or III analgesic - To evaluate patients pain relief using a Likert 4-class scale (complete or substantial relief, moderate relief slight relief and absence of relief) at D5 - To evaluate changes in intensity of pain when moving, over the entire day, measured at the end of the day using a numeric scale, over 5 days - To evaluate the patients overall satisfaction at the end of treatment using a 4-point Simple Verbal Scale (SVS) (very satisfied, somewhat satisfied, somewhat unsatisfied, very unsatisfied) - To evaluate the patients overall satisfaction at the end of the study using a 4-point Simple Verbal Scale (EVS) (very satisfied, somewhat satisfied, somewhat unsatisfied, very unsatisfied) - To compare the safety of the two treatments

NCT ID: NCT00808327 Completed - Pain Clinical Trials

Spinal Anesthesia for Cesarean Delivery: Bupivacaine With or Without Fentanyl

Start date: January 2009
Phase: N/A
Study type: Interventional

The safest form of anesthesia for Cesarean section is a spinal anesthetic. All spinal anesthetics contain a local anesthetic and/or a narcotic. A drug named bupivacaine is the most commonly used local anesthetic in spinal anesthetics for Cesarean deliveries in North America. Another drug named fentanyl is the most commonly used narcotic. This study will look at whether a spinal anesthetic with 15mg of bupivacaine alone will be the same as a spinal anesthetic with 12mg of bupivacaine and 15ug of fentanyl.

NCT ID: NCT00808054 Completed - Pain Clinical Trials

Evaluation of Analgesia With EMLA and Glucose Oral Solution

Start date: November 2008
Phase: Phase 4
Study type: Interventional

In this randomized controlled study the investigators intended to compare analgesic effects of EMLA and/or oral glucose in 60 preterm neonate during arterial function and PICC installation.

NCT ID: NCT00806247 Completed - Pain Clinical Trials

A Randomized, Double-Blind, Parallel-Arm, Placebo and Active Controlled Dose-Ranging Study of the Efficacy and Safety of Multiple Doses of Tapentadol IR for Postoperative Pain Following Bunionectomy Surgery

Start date: January 2005
Phase: Phase 2
Study type: Interventional

This study was to evaluate the efficacy and safety of dosing regimens of tapentadol HCl immediate release capsules for the treatment of postoperative pain over a period of 12 hours on the first day following a bunionectomy in men and women.

NCT ID: NCT00805142 Completed - Pain Clinical Trials

Phase 2 Study of Tapentadol Prolonged Release in Cancer Pain Participants

Start date: November 2008
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the efficacy, safety and pharmacokinetics (how the drug is absorbed in the body, distributed within the body, and how it is removed from the body over time; explores what the body does to the drug) of tapentadol prolonged release (JNS024PR, PR) in participants with moderate to severe cancer (abnormal tissue that grows and spreads in the body until it kills) pain.

NCT ID: NCT00804362 Completed - Pain Clinical Trials

Validation of the Sickle Cell Disease Pain Burden Interview

Start date: December 2008
Phase: N/A
Study type: Observational

The purpose of this study is to validate a brief survey tool, the SCD Pain Burden Interview (SCPBI), which can be used in the clinical and/or research settings to assess the impact of pain on children with sickle cell disease.